Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 201171
Company: MYLAN

Products on ANDA 201171

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
SILDENAFIL CITRATE	SILDENAFIL CITRATE	EQ 25MG BASE	TABLET;ORAL	Discontinued	None	No	No
SILDENAFIL CITRATE	SILDENAFIL CITRATE	EQ 50MG BASE	TABLET;ORAL	Discontinued	None	No	No
SILDENAFIL CITRATE	SILDENAFIL CITRATE	EQ 100MG BASE	TABLET;ORAL	Discontinued	None	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 201171

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
03/25/2019	ORIG-1	Approval				Label is not available on this site.